SEC3 Mutations Are Synthetically Lethal With Profilin Mutations and ...
Christopher Ma, Johnson Tran, Catherine Li, Lakshmi ... · 1 Secondary Mutations Correct Fitness...
Transcript of Christopher Ma, Johnson Tran, Catherine Li, Lakshmi ... · 1 Secondary Mutations Correct Fitness...
1
Secondary Mutations Correct Fitness Defects in Toxoplasma gondii with Dinitroaniline
Resistance Mutations
Christopher Ma, Johnson Tran, Catherine Li, Lakshmi Ganesan, David Wood,
and Naomi Morrissette
Department of Molecular Biology and Biochemistry,
University of California, Irvine, Irvine CA, 92697
Genetics: Published Articles Ahead of Print, published on September 9, 2008 as 10.1534/genetics.108.092494
2
Corresponding author:
Naomi Morrissette
Department of Molecular Biology and Biochemistry
University of California, Irvine
Irvine CA 92697-3900
(949) 824-9243 (phone)
(949) 824-8551 (fax)
Running title: Secondary Mutations in Tubulin
Key words: Apicomplexa, oryzalin, replication, microtubule
Abstract word count: 200
3
ABSTRACT
Dinitroanilines (oryzalin, trifluralin, ethafluralin) disrupt microtubules in protozoa but not
vertebrate cells, causing selective death of intracellular Toxoplasma gondii parasites without
affecting host cells. Parasites containing α1-tubulin point mutations are dinitroaniline resistant
but show increased rates of aberrant replication relative to wild type parasites. T. gondii
parasites bearing the F52Y mutation were previously demonstrated to spontaneously acquire two
intragenic mutations that decrease both resistance levels and replication defects. Parasites
bearing the G142S mutation are largely dependent on oryzalin for viable growth in culture. We
isolated 46 T. gondii lines that have suppressed microtubule defects associated with the G142S
or the F52Y mutations by acquiring secondary mutations. These compensatory mutations were
α1-tubulin pseudorevertants or extragenic suppressors (the majority alter the β1-tubulin gene).
Many secondary mutations were located in tubulin domains that suggest that they function by
destabilizing microtubules. Most strikingly, we identified eight novel mutations that localize to
an eight amino acid insert that stabilizes the α1-tubulin M loop, including one (P364R) that acts
as a compensatory mutation in both F52Y and G142S lines. These lines have reduced
dinitroaniline resistance but most perform better than parental lines in competition assays,
indicating that there is a tradeoff between resistance and replication fitness.
4
INTRODUCTION
Toxoplasma gondii is a human pathogen grouped within the Apicomplexa, a phylum of
protozoa which are all obligate intracellular parasites (LEVENE 1988). Infection with this parasite
can be life-threatening in immunocompromised individuals and cause birth defects or
miscarriage during fetal infection (BLACK and BOOTHROYD 2000). Other apicomplexans such as
Plasmodium spp. and Cryptosporidium spp. have considerable medical importance or are animal
pathogens that affect livestock. Apicomplexans have a specialized apex which contains unique
organelles that coordinate invasion of host cells (MORRISSETTE and SIBLEY 2002a). These
parasites are delimited by a pellicle, a composite structure formed by the association of the
plasma membrane with the inner membrane complex, an assemblage of flattened vesicles. The
invasive stages of apicomplexan parasites have two microtubule populations: subpellicular
microtubules and spindle microtubules. Subpellicular microtubules are non-dynamic; they
maintain both apical polarity and the characteristic crescent shape of the parasite by interacting
with the cytoplasmic face of the pellicle. Spindle microtubules form an intra-nuclear spindle to
coordinate chromosome segregation. Both populations are critically important to parasite
survival and replication.
Microtubules are built by the polymerization of α-β-tubulin heterodimers and typically
contain 13 protofilaments. Protofilaments are formed by longitudinal head-to-tail association of
heterodimers and laterally associate to assemble the microtubule lattice (DOWNING and NOGALES
1998). Biochemical and structural studies have elucidated the roles of tubulin domains which are
important to the regulation of microtubule polymerization and depolymerization. Both α- and β-
tubulins have H1-S2 (N) and M loops which coordinate contacts between adjacent
protofilaments (DOWNING and NOGALES 1998; LI et al. 2002; LOWE et al. 2001; NOGALES et al.
5
1999; NOGALES et al. 1997). α-tubulin contains an eight amino acid insert missing from the
analogous region of β-tubulin which stabilizes the α-tubulin M-loop to promote protofilament
lateral association. Both α- and β-tubulins bind to GTP; however, only β-tubulin GTP can be
exchanged or hydrolyzed while α-tubulin GTP plays a structural role in this subunit (ANDERS
and BOTSTEIN 2001; DAVID-PFEUTY et al. 1977; NOGALES et al. 1998; SAGE et al. 1995a; SAGE
et al. 1995b). The β-tubulin subunits are stimulated to hydrolyze GTP in a polymerization-
dependent fashion by association of a GTPase activating domain from the α-tubulin subunit of
the adjacent dimer within the protofilament. Structural evidence indicates that GTP-bound
dimers have a conformation that facilitates protofilament contacts by both α- and β-subunits.
After hydrolysis, GDP-tubulin dimers have a kinked conformation that is believed to weaken
lateral contacts to promote microtubule disassembly (NOGALES and WANG 2006a; NOGALES and
WANG 2006b; NOGALES et al. 2003; WANG et al. 2005; WANG and NOGALES 2005).
Protozoan parasites are sensitive to dinitroaniline compounds which disrupt microtubules
to inhibit replication (BHATTACHARYA et al. 2002; BOGITSH et al. 1999; MAKIOKA et al. 2000;
STOKKERMANS et al. 1996; TRAUB-CSEKO et al. 2001). Given that these compounds are inactive
against vertebrate or fungal tubulins, the mechanism of dinitroaniline action is of particular
interest for development of new anti-microbial therapies. Our assays, as well as data from others,
indicate that wild type T. gondii parasites have an IC50 value of 0.25 μM for the dinitroaniline
oryzalin and display aberrant phenotypes in culture at 0.5 μM oryzalin (MORRISSETTE and
SIBLEY 2002b; STOKKERMANS et al. 1996). Although extracellular parasites are refractory to the
effects of microtubule-disrupting drugs, during intracellular growth, parasite microtubules are
dynamic and are sensitive to disruption by submicromolar concentrations of oryzalin or other
dinitroanilines.
6
Dinitroaniline selectivity is associated with restricted binding to sensitive (plants and
protozoa) but not resistant (vertebrates and fungi) tubulin (CHAN and FONG 1990; HESS and
BAYER 1977; HUGDAHL and MOREJOHN 1993; MOREJOHN et al. 1987). Studies using molecular
dynamics analysis and compound docking indicate that dinitroanilines interact with a consistent
site on multiple conformations of α-tubulin derived from independent molecular dynamics
models of T. gondii, Leishmania spp. and Plasmodium spp. tubulins (MITRA and SEPT 2006;
MORRISSETTE et al. 2004). Parallel analysis of vertebrate (bovine) α-tubulin reveals that
dinitroanilines have non-specific, low affinity interactions and no consensus binding site,
consistent with in vivo and in vitro observations that these compounds do not bind to vertebrate
tubulin or disrupt vertebrate microtubules. This work predicts a binding site on parasite α-
tubulin that is located beneath the H1-S2 (N) loop. Since this loop participates in protofilament
interactions, the binding site location suggests that dinitroanilines disrupt lateral contacts in the
microtubule lattice. Consistent with this notion, a comparison of α-tubulin molecular dynamics
simulations in the presence and absence of bound drug suggests that dinitroaniline binding
profoundly limits flexibility of the α-tubulin H1-S2 loop which is drawn in towards the core of
the tubulin dimer (MITRA and SEPT 2006).
T. gondii is a haploid organism for most of its life cycle, although it is capable of sexual
recombination during a transient diploid zygote stage. There are three α- and three β-tubulin
genes in the genome: the α2- gene appears to be gamete stage specific and the divergent α3- gene
may be used to construct the conoid, an unusual structure built of tubulin sheets rather than
microtubules (HU et al. 2002). The α1- and β1-tubulin genes are the dominantly expressed
forms in the proliferative (tachyzoite) stage of the parasite studied here. We have previously
identified a number of α1-tubulin point mutations associated with oryzalin resistance in T. gondii
7
(MA et al. 2007; MORRISSETTE et al. 2004). The mutations are distributed throughout the linear
sequence of α1-tubulin. However, when mapped onto a model of T. gondii α1-tubulin based on
the structure of the vertebrate tubulin dimer, many of the mutations cluster in specific domains of
the protein. For example, many mutations are located in or near domains that are associated with
microtubule stability or in the core of α-tubulin, adjacent to or within the dinitroaniline binding
site identified by computational methods. Our working model suggests that most tubulin
mutations confer dinitroaniline resistance by one of two possible mechanisms: (1) increasing
subunit affinity within the microtubule to compensate for the action of bound drug and (2) by
reducing the affinity of the tubulin for dinitroanilines by changes to the compound binding site.
Our previous observations that diverse mutations to α1-tubulin are sufficient to confer
resistance to dinitroanilines such as oryzalin in the protozoan parasite T. gondii might suggest
that dinitroaniline binding site ligands are not appropriate for development of anti-parasitic
agents. However, in many cases, drug resistance mutations isolated under laboratory conditions
are not observed in clinical settings since parasites are incapable of robust growth in natural
reservoirs. For example, a subset of laboratory selected dihydrofolate reductase (DHFR)
mutations that confer pyrimethamine resistance in P. falciparum are either rare or not observed
in the field (BATES et al. 2004; HANKINS et al. 2001; HASTINGS et al. 2002). Moreover, studies
that have exploited growth competition assays to assess the fitness of T. gondii strains bearing
wild-type or pyrimethamine resistant DHFR genes have concluded that even mutant strains that
behave similarly to wild-type parasites in vitro can display growth defects in vivo (FOHL and
ROOS 2003). We show here that dinitroaniline-resistant parasites have reduced fitness reflected
by increased rates of replication defects and poor performance in growth competition assays.
These lines rapidly and spontaneously acquire compensatory mutations that correct the fitness
8
defects and reduce resistance to dinitroanilines. We conclude that drugs that selectively target
parasite microtubules remain a realistic option for the development of new anti-parasitic
therapies.
MATERIALS AND METHODS
Culture of Toxoplasma lines: T. gondii tachyzoites (the standard RH strain and mutants
derived from the RH strain) were propagated in human foreskin fibroblast (HFF) cells in DMEM
with 10% FBS as previously described (ROOS et al. 1994). Oryzalin (Riedel-deHaen, Germany)
stock solutions were made up in DMSO. Lines bearing oryzalin-resistance mutations were
propagated in 0.5 µM oryzalin to suppress selection of secondary mutations.
Selection of suppressors: T. gondii lines bearing allelic replacements of the F52Y or
G142S mutations to the α1-tubulin gene were generated as previously described (MA et al. 2007;
MORRISSETTE et al. 2004). These lines were serially passed for 3-4 weeks in the absence of
oryzalin to select for spontaneous mutants with improved growth. After single-cell cloning, the
clones displayed robust growth and each of the lines analyzed represents an independently
derived (non-sibling) lineage. Clonal lines were analyzed for changes to the α1- or β1-tubulin
genes.
Analysis of tubulin point mutations: The α1- and β1-tubulin genes were amplified from
genomic DNA isolated from individual parasite lines as previously described (MA et al. 2007;
MORRISSETTE et al. 2004). The α1-tubulin gene was amplified using thermal cycling with
primers GAGTCTCGTAGAGAACAAGC (5’ UTRA) and CGTTTATACCTTCACCTTTTC (3’
UTRA), and the purified fragment was sequenced as previously described. The β1-tubulin gene
was amplified with primers GTGGTGTTGCGCCTTC (5’ UTRB) and CGAGTGTTTAG-
9
GACAGTGAC (3’ UTRB) and was sequenced with the following primers: (BT3E1)
CATTCTCCGCGATTCTC; (BT5E2) GTCCGGGTGTTCCTAC; (BTF2a) CATCATGGAG-
ACTTTCTCC; (BTR2a) GGAGAAAGTCTCCATGATG; (BTF2b) CAAAGAACATGATG-
TGCG; (BTR2b) CGCACATCATGTTCTTTG; (BT3E2) CTCGTCCATACC TTCACC;
(BT5E3) GAGATGGCACATTTAGTGTG; (BT3E3) CTCCCTCTTCCTCTGC; and (BT5E4)
CCGAGTATCAGCAGTACC. DNA sequences were analyzed using Sequencher software
(GeneCodes) to identify point mutations in the coding sequence of the α1-tubulin or β1-tubulin
genes. We also checked lines for α2-, α3-, β2- and β3-tubulin mutations but did not identify any
changes to these genes.
Structural models of T. gondii tubulin: Point mutations were mapped onto models of
T. gondii tubulin using PyMol (DELANO 2002). The models (containing a rebuilt H1-S2 loop)
were previously generated for computational studies (MITRA and SEPT 2006; MORRISSETTE et al.
2004).
Immunofluorescence staining: Extracellular parasites were fixed, permeablized and
stained in suspension as previously described (MORRISSETTE and SIBLEY 2002b). The T. gondii
plasma membrane was labeled with DG52 antibody (BURG et al. 1988) and detected with an
Alexa 594 secondary antibody (Invitrogen). DNA was visualized with DAPI. Suspension
samples were allowed to settle onto 35 mm dishes with glass coverslip insets (MatTek). Images
were collected on a Zeiss Axioskop using the Axiovision camera and software. Images were
exported and manipulated in Photoshop 8.0.
Quantification of replication defects: T. gondii were passed into HFF cells without
oryzalin selection and allowed to grow until complete host cell lysis. Extracellular parasites
were viewed in suspension in MatTek dishes with a coverslip inset using a 63X phase-contrast
10
lens on a Zeiss Axioskop microscope. Images were captured as tif files and scored by counting
as previously described (MA et al. 2007). In order not to under-represent aberrant forms, we
counted the number of apical regions to establish total parasites lost from the parasite population
through replication defects.
Competition assays: T25 flasks with confluent HFF cells were inoculated with a 1:1 ratio
of RH strain-derived lines described here and wild type (RH strain) parasites expressing
cytosolic GFP (1x107 parasites from each line) (KIM et al. 2001) . After host monolayer lysis, a
new T25 flask with confluent HFF cells was inoculated with 1.0 ml of the lysed culture and the
remaining material (5ml) was used for flow cytometry analysis. Extracellular parasites were
purified away from host cell debris by passing lysate through a 3 μm filter. After parasites were
collected by centrifugation (all spins performed at 6,000 RPM for 6 min), they were fixed in
1.0% formalin (Sigma) for 1 min at RT. After a PBS wash, parasites were blocked in 10% (w/v)
BSA/PBS (Fisher Scientific, 30 min, 4oC) and surface labeled with DG52 anti-P30/SAG1 mouse
antibody (30 min, 4oC, 1:1000 in 10% (w/v) BSA/PBS) and a PE-Cy5.5 conjugated goat anti-
mouse secondary antibody (Invitrogen, 30 min, 4oC, 1:1000 in 10% (w/v) BSA/PBS). The total
number of parasites (PE-Cy5.5 labeling) and the number of parasites with GFP fluorescence
were enumerated by flow cytometry using a FACSCalibur flow cytometer (Becton Dickinson,
Inc.) and analyzed with Flowjo software (Tree Star, Inc.). The trend lines represent the
percentage of total mutant parasites at each time point, and the analysis was carried out for 7 and
15 serial parasite passages.
11
RESULTS
Toxoplasma α1-tubulin mutations are associated with oryzalin resistance but have
fitness defects: We previously isolated a number of T. gondii lines that have mutations to α1-
tubulin which are sufficient to confer resistance to dinitroanilines such as oryzalin (MA et al.
2007; MORRISSETTE et al. 2004). Among the lines isolated in our work, are two that are oryzalin
resistant due to point mutations F52Y or G142S in the α1-tubulin gene (Figure 1). Parasites
bearing the G142S mutation are resistant to 1.0 μM oryzalin. G142 participates in binding the α-
phosphate portion of GTP (GIGANT et al. 2000; LOWE et al. 2001), and parasites with the G142S
mutation are largely dependent on the presence of oryzalin for viable growth in culture. F52 is
located in the H1-S2 loop, a domain that is critically important for protofilament-protofilament
associations in the microtubule lattice (LI et al. 2002). Parasites bearing the F52Y mutation have
high rates of defective replication and have been shown to spontaneously acquire compensatory
mutations. We previously reported that parasites with the F52Y mutation were resistant to 7 μM
oryzalin (MA et al. 2007). In the course of carrying out the experiments reported here, we
discovered that parasites bearing this mutation rapidly acquire secondary mutations (even when
under 0.5 μM oryzalin selection) and that the true resistance of the parental line is 13 μM.
Relative to wild type T. gondii, both F52Y and G142S parasite lines have high rates of overt
replication defects (Figure 1B and C).
Defects are corrected by compensatory mutations in lines derived from the two
parental parasite strains: When T. gondii parasites bearing an allelic integration of the F52Y or
G142S mutation are passed for several generations in the absence of oryzalin selection, they
spontaneously acquire mutations that allow them to grow with increased robustness. After
single-cell cloning independently selected lines with improved growth, we analyzed the
12
sequences of T. gondii α1- and β1-tubulin genes for mutations associated with suppression of
defects. We identified both α1-tubulin pseudorevertants and extragenic mutations in β1-tubulin
and other (unidentified) genes. We isolated twenty-seven independent lines from the F52Y line
and identified mutations that localize to α1-tubulin or β1-tubulin in twenty-two of these lines
(Figure 2 and Table 1). Three of the α1-tubulin mutations are located in the M or H1-S2 (N)
loops and seven mutations are located in the eight amino acid α-tubulin specific insert. Six of
the lines have mutations to the β1-tubulin gene; three of these are in the M or H1-S2 (N) loops.
The G142S resistance mutation alters the GGGTGSG tubulin motif which is associated with
binding the phosphate portion of GTP. Of the twenty-four G142S derived lines characterized
here, thirteen acquire a secondary mutation in the α1-tubulin gene (Figure 3 and Table 2). One of
these mutations is associated with GTP binding (S171A), two localize in the eight amino acid α-
tubulin specific insert and one is in the M loop. We also isolated ten lines with extragenic
suppressors, with eight of these occurring in the β1-tubulin gene and two being in other,
unidentified loci. During the course of these studies we did not identify any true revertants of
F52Y or G142S parasites.
Growth competition assays indicate that the derived lines have increased fitness
relative to the parental strains: We have exploited an established GFP-expressing T. gondii
line to assess the relative fitness of the F52Y and G142S parasite lines and the derived progeny
(KIM et al. 2001). Both the GFP-expressing line and the tubulin mutant lines are derived from
RH strain T. gondii. We co-infected HFF cells with an equivalent number of GFP-expressing
parasites and parasites of each tubulin mutant line, and exploited green fluorescence to follow
the relative rates of replication and growth over serial passage (Figure 4). Parasites from lysed
flasks were used to inoculate new flasks such that they would lyse the host cell monolayer in 2
13
days time. The remainder of each sample was analyzed by flow cytometry. In initial
experiments, the parasites were labeled with the DG52 (anti-SAG1) antibody to ensure that the
entire parasite population was visualized for analysis (Figure 4 inset). Once we were confident
that our gating captured the parasite population, we omitted the DG52 labeling, with consistent
results. At each time point, the total number of parasites and the number of GFP labeled parasite
were determined. Non-fluorescing parasites represent the fraction of the population expressing
the specific tubulin mutation(s). These growth competition assays indicate that the F52Y and
G142S lines compete poorly with wild-type-GFP parasites (Figure 4). After 6 days, the G142S
line is not detectable and at 8 days the F52Y line cannot be detected. In contrast, the β1-P61A
and α1-P364R lines which are derived from the G142S and F52Y parasites are still present at
this time, although their declining percentage in the population indicates that they are less fit than
the GFP-RH line. As a control, we also carried out growth competition for wild type RH
parasites versus the GFP-expressing parasites. Over time, we reproducibly observed that the
GFP-expressing parasites were at a disadvantage relative to the wild type RH T. gondii.
Therefore, the growth competition using GFP-RH parasites underestimates the fitness defects
associated with the dinitroaniline resistance mutations and the associated suppressed lines. We
analyzed all of the F52Y and G142S derived lines after two weeks (14 days) in serial passage
with GFP-RH parasites to assess relative fitness relationships in competition with wild type
parasites (Figure 5 and 6). In most cases, lines with compensatory mutations do not fully recover
robust growth. The most effective F52Y derived lines with respect to fitness are point mutations
at T51A (the α-tubulin H1-S2 loop), P364A (the α-tubulin insert) and G34S (the β-tubulin H1-S2
loop), which are still all less than 50% of the culture after 2 weeks (Figure 5 and Table 3). The
most effective G142S derived lines are S171A (an α-tubulin GTP binding site residue), L230V
14
(located in helix 7 of α-tubulin) and V363A (in the α-tubulin insert). The L230V line is present
at ~50% of the culture after two weeks (Figure 6 and Table 3). However, since the GFP-RH
parasites have a fitness defect relative to unlabeled RH strain wild type parasites, it is still likely
that the L230V line would compete unfavorably with wild type T. gondii.
The derived lines have diminished oryzalin resistance relative to the parental
strains: The F52Y and G142S parasite lines display 13 and 1.0 µM oryzalin resistance,
respectively. Lines derived from these parental strains display reduced oryzalin resistance
(Figure 5 and 6 and Table 3). With respect to the F52Y derived lines, the P364A line retains the
highest level of oryzalin resistance (7 μM) and competes relatively well with the GFP-RH
parasites. Since the G142S line parasites have 1 μM oryzalin resistance, the range of resistance
observed in the derived lines is substantially lower. A number of the lines (the Q256H, S287P,
V363A mutations in α-tubulin and the P358R and A393V mutations in β-tubulin) do not have
greater resistance to oryzalin than that observed for wild type parasites (<0.5 μM by
morphological criteria). Lines with secondary mutations at S171A and L230V retain the highest
levels of oryzalin resistance in the context of the greatest degree of overall fitness in the
competition assay. All 46 lines bearing compensatory mutations are associated with diminished
oryzalin resistance.
DISCUSSION
Previous genetic studies have identified secondary mutations that correct tubulin
associated defects. In studies of colchicine resistance, intragenic mutations correct defects
associated with the D45Y mutation to β-tubulin which confers colchicine resistance in CHO cells
(WANG et al. 2004). This substitution is located in the H1-S2 loop and since it increases
15
microtubule stability, cells that express it are hypersensitive to Taxol. Lines that suppress the
Taxol hypersensitivity and associated temperature sensitive defects have point mutations at
V60A (the H1-S2 loop) or Q292H (near the M loop) of β-tubulin that alter microtubule stability.
When wild type CHO cells express a tagged β-tubulin construct bearing the D45Y mutation, the
microtubule array is strikingly denser relative to the array observed with expression of wild type
tubulin alone. Inclusion of secondary mutations in the β-tubulin constructs reduces the
microtubule array making it similar to that observed with expression of wild type tubulin. When
β-tubulin constructs with the V60A and Q292H secondary mutations alone are expressed, the
microtubule arrays are dramatically reduced relative to those observed with wild type tubulin
expression. These observations are strikingly similar to our results described here. The F52Y
mutation is predicted to increase microtubule stability to confer dinitroaniline resistance, but also
causes increased rates of replication defects. Secondary mutations are located in regions such as
the H1-S2 loop, the M loop and the α-tubulin insert domain which are predicted to decrease
microtubule stability. We attempted to express GFP-tagged vertebrate tubulin with analogous
mutations in COS cells to visualize differential assembly of these tubulins. Unfortunately,
expression appears to be somewhat toxic and the patterns were too variable to be used to assess
relative stability of tubulins with these mutations (JT and NM, data not shown).
Many of the secondary mutations are identical or quite similar to previously identified
mutations that decrease microtubule stability in Caenorhabditis elegans and Arabidopsis
thaliana. C. elegans sensory neuron function requires unusual 15-protofilament microtubules
(CHALFIE 1982; CHALFIE et al. 1986; CHALFIE and THOMSON 1979; CHALFIE and THOMSON
1982; SAVAGE et al. 1989; SAVAGE et al. 1994). These microtubules are built from dimers
encoded by distinct α- (mec-12+) and β- (mec-7+) tubulin genes (FUKUSHIGE et al. 1999; GU et
16
al. 1996; SAVAGE et al. 1989; SAVAGE et al. 1994). A number of mec-7 and mec-12 alleles have
been identified in screens for sensory neuron defects. In addition, mutations in Arabidopsis that
convert linear growth of plant parts (such as roots and stems) to a twisted phenotype have altered
cortical microtubule arrays. This twisting morphology can be phenocopied by treatment of wild
type plants with the microtubule inhibitor propyzamide. Many of the twisting mutants have
mutations to α- and β-tubulin mutations that decrease microtubule stability and increase plant
sensitivity to microtubule disrupting drugs (ABE and HASHIMOTO 2005; ABE et al. 2004; ISHIDA
and HASHIMOTO 2007; ISHIDA et al. 2007a; ISHIDA et al. 2007b; NAKAJIMA et al. 2004;
NAKAJIMA et al. 2006; SHOJI et al. 2004; THITAMADEE et al. 2002). The β-tubulin mutation
G34S (a F52Y suppressor) was previously identified as a mild, recessive mec-7 allele (SAVAGE
et al. 1989). Other mec-7 alleles (P61L/S, G269D, R318G and A393T) alter equivalent residues
to different substitutions in T. gondii β-tubulin (the F52Y suppressor G269V and the G142S
suppressors P61A, R318C and A393V). The G142S secondary mutation I355E in α-tubulin is
adjacent to the location of the mec-12 allele G354E. Moreover, the A393 residue is also
identified as a threonine substitution causing twisting in Arabidopsis β-tubulin (A394T). The
F52Y compensatory mutations V181I and K280N in α-tubulin and H396Q in β-tubulin and the
G142S mutation P348L (α-tubulin) are near the twisting mutations S180P, A180T, A281T and
T349I (α-tubulin) and A394T (β-tubulin). Lastly, the G142S suppressor Q291E is adjacent to a
second glutamine at 292 that is a mec-7 allele (Q292P). This residue also influences microtubule
stability in the context of epothilone resistance (Q292G) and suppresses hyperstabilized
microtubules (Q292H) in D45Y colchicine-resistant cells (HE et al. 2001; WANG et al. 2004).
One of the novel findings presented in this work is the identification of a set of eight
mutations that localize to the α-tubulin specific insert (TVVPGGDL). The compensatory
17
mutations in the F52Y line that localize to the insert are T361P, P364A, P364R, G366R, D367V
and L368F and the G142S line mutations are V363A and P364R. To our knowledge, the insert
substitutions represent the first description of mutations located in this highly conserved domain.
We hypothesize that these substitutions impair the ability of the insert to promote M loop lateral
contacts with the adjacent protofilament. Indeed, the D367V mutation eliminates a salt bridge
that occurs with R229 (MA et al. 2007). Strikingly, the P364R mutation functions as a
compensatory mutation in both lines, albeit more successfully in the F52Y line (compare
competition results in Figures 5 and 6 and Table 3). Although the G142S/P364R line does not
compete effectively enough with wild type parasites to remain in the culture at 14 days, it was
isolated as a line with improved growth over the G142S line and at some subtle level is likely to
improve fitness of the parental line. This is also likely to be the explanation for the F52Y
suppressor A295G in competition at 14 days (Table 3).
The studies presented here show a correlation between acquisition of increased fitness
and the appearance of mutations to the α1- or β1-tubulin genes. While the improved fitness
observed in parasite lines derived from the F52Y and G142S parental strains is likely to be due
to secondary tubulin mutations, other (non-tubulin) mutations may also contribute to the
observed phenotypes of decreased resistance and enhanced growth. Indeed, five of the lines
derived from the F52Y suppressor screen and one line derived from the G142S suppressor screen
have improved growth but do not have altered α1-, α3-, β1-, or β3- tubulin genes suggesting that
non-tubulin compensatory mutations do arise. Moreover, although we can and have created
allelic replacements for two α-tubulin pseudorevertants in wild type parasites (MA et al. 2007),
we cannot create allelic replacements for the β-tubulin suppressors since we cannot select for
these in the absence of dinitroaniline selection. When we analyzed the allelic replacements for
18
the α-tubulin pseudorevertants (F52Y/A273V and F52Y/D367V) in the competition assay, they
performed differently from the equivalent lines with these spontaneous mutations. Surprisingly,
in both cases the transgene versions of the lines had greater fitness levels than the spontaneous
mutant lines (data not shown). The suppressed lines described here were isolated after 4-6 weeks
of growth in media without oryzalin. This represents the shortest time in which we could observe
parasites with new mutations. In contrast, it takes at least 6 weeks to isolate transgene-bearing
lines. We predict that further growth of lines with impaired fitness in the absence of oryzalin
selection would select for additional mutations that collectively contribute to increased fitness.
Previous studies have established that there is a tradeoff between carrying genes that
confer drug resistance and the fitness cost of these altered alleles, particularly in the absence of
drug selection. Recent field studies from Malawi indicate that Plasmodium falciparum parasites
in this region lost resistance to chloroquine in fewer than ten years after sulfadoxine-
pyrimethamine treatment replaced chloroquine treatment for individuals suffering from malaria
(LAUFER et al. 2006; VOGEL 2006). These field observations, as well as the controlled laboratory
studies of DHFR mutations in P. falciparum and T. gondii described in the Introduction, indicate
that the existence of mutant lines that express resistant forms of target proteins does not rule out
the development and use of agents that inhibit these proteins. With respect to the studies
presented here, we believe that although dinitroanilines or other microtubule disrupting
compounds do not yet exist in an appropriate form for treatment of parasite infections,
selectively targeting protozoan tubulin remains a viable strategy for eliminating parasite
infections.
19
ACKNOWLEDGEMENTS
We thank Dan Sackett for commenting on this manuscript, David Sibley and Michael
Grigg for helpful conversations on competition assays and Sheryl Tsai bringing clarity to
PyMOL commands. Research presented in this paper was supported by NIH grants AI055790
and AI067981 to NSM. LG and DW are undergraduate students in the campus-wide honors
program at UCI and LG was supported by a UCI SURP fellowship. We would like to thank
Candice Kwark and Brian Luk, high school student participants in the American Cancer Society
summer research program at UCI, who helped select and analyze the lines described here.
20
LITERATURE CITED
ABE, T., and T. HASHIMOTO, 2005 Altered microtubule dynamics by expression of modified alpha-tubulin protein causes right-handed helical growth in transgenic Arabidopsis plants. Plant J 43: 191-204.
ABE, T., S. THITAMADEE and T. HASHIMOTO, 2004 Microtubule defects and cell morphogenesis in the lefty1lefty2 tubulin mutant of Arabidopsis thaliana. Plant Cell Physiol 45: 211-220.
ANDERS, K. R., and D. BOTSTEIN, 2001 Dominant-lethal alpha-tubulin mutants defective in microtubule depolymerization in yeast. Mol Biol Cell 12: 3973-3986.
BATES, S. J., P. A. WINSTANLEY, W. M. WATKINS, A. ALLOUECHE, J. BWIKA et al., 2004 Rare, highly pyrimethamine-resistant alleles of the Plasmodium falciparum dihydrofolate reductase gene from 5 African sites. J Infect Dis 190: 1783-1792.
BHATTACHARYA, G., M. M. SALEM and K. A. WERBOVETZ, 2002 Antileishmanial dinitroaniline sulfonamides with activity against parasite tubulin. Bioorg Med Chem Lett 12: 2395-2398.
BLACK, M. W., and J. C. BOOTHROYD, 2000 Lytic cycle of Toxoplasma gondii. Microbiol Mol Biol Rev 64: 607-623.
BOGITSH, B. J., O. L. MIDDLETON and R. RIBEIRO-RODRIGUES, 1999 Effects of the antitubulin drug trifluralin on the proliferation and metacyclogenesis of Trypanosoma cruzi epimastigotes. Parasitol Res 85: 475-480.
BURG, J. L., D. PERELMAN, L. H. KASPER, P. L. WARE and J. C. BOOTHROYD, 1988 Molecular analysis of the gene encoding the major surface antigen of Toxoplasma gondii. J Immunol 141: 3584-3591.
CHALFIE, M., 1982 Microtubule structure in Caenorhabditis elegans neurons. Cold Spring Harb Symp Quant Biol 46 Pt 1: 255-261.
CHALFIE, M., E. DEAN, E. REILLY, K. BUCK and J. N. THOMSON, 1986 Mutations affecting microtubule structure in Caenorhabditis elegans. J Cell Sci Suppl 5: 257-271.
CHALFIE, M., and J. N. THOMSON, 1979 Organization of neuronal microtubules in the nematode Caenorhabditis elegans. J Cell Biol 82: 278-289.
CHALFIE, M., and J. N. THOMSON, 1982 Structural and functional diversity in the neuronal microtubules of Caenorhabditis elegans. J Cell Biol 93: 15-23.
CHAN, M. M., and D. FONG, 1990 Inhibition of leishmanias but not host macrophages by the antitubulin herbicide trifluralin. Science 249: 924-926.
DAVID-PFEUTY, T., H. P. ERICKSON and D. PANTALONI, 1977 Guanosinetriphosphatase activity of tubulin associated with microtubule assembly. Proc Natl Acad Sci U S A 74: 5372-5376.
DELANO, W. L., 2002 The PyMOL Molecular Graphics System http://www.pymol.org, pp., Palo Alto, CA.
DOWNING, K. H., and E. NOGALES, 1998 Tubulin and microtubule structure. Curr Opin Cell Biol 10: 16-22.
FOHL, L. M., and D. S. ROOS, 2003 Fitness effects of DHFR-TS mutations associated with pyrimethamine resistance in apicomplexan parasites. Mol Microbiol 50: 1319-1327.
FUKUSHIGE, T., Z. K. SIDDIQUI, M. CHOU, J. G. CULOTTI, C. B. GOGONEA et al., 1999 MEC-12, an alpha-tubulin required for touch sensitivity in C. elegans. J Cell Sci 112 ( Pt 3): 395-403.
21
GIGANT, B., P. A. CURMI, C. MARTIN-BARBEY, E. CHARBAUT, S. LACHKAR et al., 2000 The 4 A X-ray structure of a tubulin:stathmin-like domain complex. Cell 102: 809-816.
GU, G., G. A. CALDWELL and M. CHALFIE, 1996 Genetic interactions affecting touch sensitivity in Caenorhabditis elegans. Proc Natl Acad Sci U S A 93: 6577-6582.
HANKINS, E. G., D. C. WARHURST and C. H. SIBLEY, 2001 Novel alleles of the Plasmodium falciparum dhfr highly resistant to pyrimethamine and chlorcycloguanil, but not WR99210. Mol Biochem Parasitol 117: 91-102.
HASTINGS, M. D., S. J. BATES, E. A. BLACKSTONE, S. M. MONKS, T. K. MUTABINGWA et al., 2002 Highly pyrimethamine-resistant alleles of dihydrofolate reductase in isolates of Plasmodium falciparum from Tanzania. Trans R Soc Trop Med Hyg 96: 674-676.
HE, L., C.-P. HUANG YANG and S. B. HORWITZ, 2001 Mutations in {beta}-Tubulin Map to Domains Involved in Regulation of Microtubule Stability in Epothilone- resistant Cell Lines. Mol Cancer Ther 1: 3-10.
HESS, F. D., and D. E. BAYER, 1977 Binding of the herbicide trifluralin to Chlamydomonas flagellar tubulin. J Cell Sci 24: 351-360.
HU, K., D. S. ROOS and J. M. MURRAY, 2002 A novel polymer of tubulin forms the conoid of Toxoplasma gondii. J Cell Biol 156: 1039-1050.
HUGDAHL, J. D., and L. C. MOREJOHN, 1993 Rapid and Reversible High-Affinity Binding of the Dinitroaniline Herbicide Oryzalin to Tubulin from Zea mays L. Plant Physiol 102: 725-740.
ISHIDA, T., and T. HASHIMOTO, 2007 An Arabidopsis thaliana tubulin mutant with conditional root-skewing phenotype. J Plant Res 120: 635-640.
ISHIDA, T., Y. KANEKO, M. IWANO and T. HASHIMOTO, 2007a Helical microtubule arrays in a collection of twisting tubulin mutants of Arabidopsis thaliana. Proc Natl Acad Sci U S A 104: 8544-8549.
ISHIDA, T., S. THITAMADEE and T. HASHIMOTO, 2007b Twisted growth and organization of cortical microtubules. J Plant Res 120: 61-70.
KIM, K., M. S. EATON, W. SCHUBERT, S. WU and J. TANG, 2001 Optimized expression of green fluorescent protein in Toxoplasma gondii using thermostable green fluorescent protein mutants. Mol Biochem Parasitol 113: 309-313.
LAUFER, M. K., P. C. THESING, N. D. EDDINGTON, R. MASONGA, F. K. DZINJALAMALA et al., 2006 Return of chloroquine antimalarial efficacy in Malawi. N Engl J Med 355: 1959-1966.
LEVENE, N. D., 1988 The protozoan phylum Apicomplexa. CRC Press, Boca Raton, FL. LI, H., D. DEROSIER, W. NICHOLSON, E. NOGALES and K. DOWNING, 2002 Microtubule structure
at 8 a resolution. Structure (Camb) 10: 1317. LOWE, J., H. LI, K. H. DOWNING and E. NOGALES, 2001 Refined structure of alpha beta-tubulin at
3.5 A resolution. J Mol Biol 313: 1045-1057. MA, C., C. LI, L. GANESAN, J. OAK, S. TSAI et al., 2007 Mutations in {alpha}-Tubulin Confer
Dinitroaniline Resistance at a Cost to Microtubule Function. Mol Biol Cell 18: 4711-4720.
MAKIOKA, A., M. KUMAGAI, H. OHTOMO, S. KOBAYASHI and T. TAKEUCHI, 2000 Effect of dinitroaniline herbicides on the growth of Entamoeba histolytica. J Parasitol 86: 607-610.
MITRA, A., and D. SEPT, 2006 Binding and interaction of dinitroanilines with apicomplexan and kinetoplastid alpha-tubulin. J Med Chem 49: 5226-5231.
22
MOREJOHN, L. C., T. E. BUREAU, J. MOLE-BAJER, A. S. BAJER and D. E. FOSKET, 1987 Oryzalin, a dinitroaniline herbicide, binds to plant tubulin and inhibits microtubule polymerization in vitro. Planta 172: 252-264.
MORRISSETTE, N. S., A. MITRA, D. SEPT and L. D. SIBLEY, 2004 Dinitroanilines bind alpha-tubulin to disrupt microtubules. Mol Biol Cell 15: 1960-1968.
MORRISSETTE, N. S., and L. D. SIBLEY, 2002a Cytoskeleton of apicomplexan parasites. Microbiol Mol Biol Rev 66: 21-38.
MORRISSETTE, N. S., and L. D. SIBLEY, 2002b Disruption of microtubules uncouples budding and nuclear division in Toxoplasma gondii. J Cell Sci 115: 1017-1025.
NAKAJIMA, K., I. FURUTANI, H. TACHIMOTO, H. MATSUBARA and T. HASHIMOTO, 2004 SPIRAL1 encodes a plant-specific microtubule-localized protein required for directional control of rapidly expanding Arabidopsis cells. Plant Cell 16: 1178-1190.
NAKAJIMA, K., T. KAWAMURA and T. HASHIMOTO, 2006 Role of the SPIRAL1 gene family in anisotropic growth of Arabidopsis thaliana. Plant Cell Physiol 47: 513-522.
NOGALES, E., K. H. DOWNING, L. A. AMOS and J. LOWE, 1998 Tubulin and FtsZ form a distinct family of GTPases. Nat Struct Biol 5: 451-458.
NOGALES, E., and H. W. WANG, 2006a Structural intermediates in microtubule assembly and disassembly: how and why? Curr Opin Cell Biol 18: 179-184.
NOGALES, E., and H. W. WANG, 2006b Structural mechanisms underlying nucleotide-dependent self-assembly of tubulin and its relatives. Curr Opin Struct Biol 16: 221-229.
NOGALES, E., H. W. WANG and H. NIEDERSTRASSER, 2003 Tubulin rings: which way do they curve? Curr Opin Struct Biol 13: 256-261.
NOGALES, E., M. WHITTAKER, R. A. MILLIGAN and K. H. DOWNING, 1999 High-resolution model of the microtubule. Cell 96: 79-88.
NOGALES, E., S. G. WOLF and K. H. DOWNING, 1997 Visualizing the secondary structure of tubulin: three-dimensional map at 4 A. J Struct Biol 118: 119-127.
ROOS, D. S., R. G. DONALD, N. S. MORRISSETTE and A. L. MOULTON, 1994 Molecular tools for genetic dissection of the protozoan parasite Toxoplasma gondii. Methods Cell Biol 45: 27-63.
SAGE, C. R., A. S. DAVIS, C. A. DOUGHERTY, K. SULLIVAN and K. W. FARRELL, 1995a beta-Tubulin mutation suppresses microtubule dynamics in vitro and slows mitosis in vivo. Cell Motil Cytoskeleton 30: 285-300.
SAGE, C. R., C. A. DOUGHERTY, A. S. DAVIS, R. G. BURNS, L. WILSON et al., 1995b Site-directed mutagenesis of putative GTP-binding sites of yeast beta-tubulin: evidence that alpha-, beta-, and gamma-tubulins are atypical GTPases. Biochemistry 34: 7409-7419.
SAVAGE, C., M. HAMELIN, J. G. CULOTTI, A. COULSON, D. G. ALBERTSON et al., 1989 mec-7 is a beta-tubulin gene required for the production of 15-protofilament microtubules in Caenorhabditis elegans. Genes Dev 3: 870-881.
SAVAGE, C., Y. XUE, S. MITANI, D. HALL, R. ZAKHARY et al., 1994 Mutations in the Caenorhabditis elegans beta-tubulin gene mec-7: effects on microtubule assembly and stability and on tubulin autoregulation. J Cell Sci 107 ( Pt 8): 2165-2175.
SHOJI, T., N. N. NARITA, K. HAYASHI, J. ASADA, T. HAMADA et al., 2004 Plant-specific microtubule-associated protein SPIRAL2 is required for anisotropic growth in Arabidopsis. Plant Physiol 136: 3933-3944.
23
STOKKERMANS, T. J., J. D. SCHWARTZMAN, K. KEENAN, N. S. MORRISSETTE, L. G. TILNEY et al., 1996 Inhibition of Toxoplasma gondii replication by dinitroaniline herbicides. Exp Parasitol 84: 355-370.
THITAMADEE, S., K. TUCHIHARA and T. HASHIMOTO, 2002 Microtubule basis for left-handed helical growth in Arabidopsis. Nature 417: 193-196.
TRAUB-CSEKO, Y. M., J. M. RAMALHO-ORTIGAO, A. P. DANTAS, S. L. DE CASTRO, H. S. BARBOSA et al., 2001 Dinitroaniline herbicides against protozoan parasites: the case of Trypanosoma cruzi. Trends Parasitol 17: 136-141.
VOGEL, G., 2006 Malaria. Chloroquine makes a comeback. Science 314: 904. WANG, H. W., S. LONG, K. R. FINLEY and E. NOGALES, 2005 Assembly of GMPCPP-bound
tubulin into helical ribbons and tubes and effect of colchicine. Cell Cycle 4: 1157-1160. WANG, H. W., and E. NOGALES, 2005 Nucleotide-dependent bending flexibility of tubulin
regulates microtubule assembly. Nature 435: 911-915. WANG, Y., S. VEERARAGHAVAN and F. CABRAL, 2004 Intra-allelic suppression of a mutation that
stabilizes microtubules and confers resistance to colcemid. Biochemistry 43: 8965-8973.
24
FIGURE LEGENDS
FIGURE 1. — (A) The F52Y and G142S α-tubulin point mutations confer 13 and 1 µM oryzalin
resistance when integrated into wild type (sensitive) T. gondii parasites. The F52Y mutation
(red) is located in the H1-S2 (N) loop (red) of α1-tubulin. The computationally determined
dinitroaniline binding site is below this loop (oryzalin shown in orange). Interactions between
the H1-S2 (N) loop and the M loop of adjacent dimers coordinate lateral associations between
protofilaments in the microtubule lattice. The G142S mutation is located in the core of α1-
tubulin and the G142 residue represents the initial glycine in the GGGTGSG motif (blue) which
is characteristic of tubulins. This motif is part of the GTP binding site which is essential for
correct folding of the tubulin dimer and interacts with the phosphate portion of GTP (purple). (B)
Quantification of replication defects in the absence of oryzalin. The results for F52Y parasites
were previously published in (MA et al. 2007) and are shown here for purposes of comparison
with the G142S line. (C) Immunofluorescence images of extracellular parasites of the G142S
line labeled with DG52 (red, labels the parasite surface) and DAPI (blue, labels the parasite
DNA). The lower panel shows DNA distribution only. (1) A normal appearing parasite has a
crescent shape and DNA staining of the nucleus (arrow) and apicoplast DNA (arrowhead). (2-6)
Parasite “monsters” result from replication defects due to improper coordination of spindle
microtubule (nuclear division) and subpellicular microtubule (cytokinesis) functions. Although
the extracellular parasites in panels 3 and 4 are similar to intracellular replicating stages (see
diagram in (MA et al. 2007)), parasites can not complete division outside of host cells and their
abnormal shape prevents invasion of new host cells. In addition, panels 2, 5 and 6 illustrate
parasites with diffuse (2), improperly segregated (3 nuclei, panel 5) and non-segregated (6)
nuclear staining (compare to panel 1).
25
FIGURE 2. — Location of compensatory mutations obtained from the F52Y line mapped on a
model of the Toxoplasma tubulin dimer. The α1-subunit is colored white and the β1-subunit is
blue. (A) Most mutations fall between the M and H1-S2 loops (red) facing the inner lumen of
the microtubule. The F52Y mutation is located in the H1-S2 loop of α1-tubulin (red) and
secondary mutations in α1-tubulin (black text) occur at T51A, V181I, A273V, K280N, N293D,
A295G, S300T, M313T, P360A, T361P, P364A, P364R, G366R, D367V, L368F and R373C
(orange/yellow). Mutations in yellow localize to the α-tubulin specific insert. Extragenic
suppressors in the β1-tubulin subunit (white text) occur at G34S, G82D, P261S, G269V, L273V
and H396Q. (B) The β1-tubulin mutation P261S is the only mutation that faces the outer surface
of the dimer within the microtubule lattice, while the β-subunit mutation H396Q is located at the
dimer-dimer interface within the protofilament. (C) The mutations T361P, P364A, P364R,
G366R, D367V and L368F occur in the α-tubulin specific insert (yellow) and the mutations
P360A and R373C are adjacent to this insert (orange).
FIGURE 3. — Location of compensatory mutations obtained from the G142S line mapped on a
model of the Toxoplasma tubulin dimer (the α1-subunit is white and the β1-subunit is blue). The
G142S mutation (yellow) is located in the GTP binding domain of α-tubulin. (A) Most
mutations (orange/yellow) are on the surface of the dimer that faces the inner lumen of the
microtubule. Secondary mutations in α1-tubulin (black text) occur at I93V, G131R, S171A,
I209V, L230V, Q256H, S287P, P348L, I355E, V363A, P364R, V371G and F418I. Suppressors
in the β1-tubulin subunit (white text) occur at residues A18P, P61A, F85L, K122E, H264Q,
Q291E, R318C, N337T, P358R, M363V and A393V. G142S α1-tubulin mutations at V363A
26
and P364R occur in the α-tubulin specific insert (yellow). (B) The α1-tubulin mutation at Q256
and the β1-tubulin mutation at H264 are the only mutations that face the outer surface of the
dimer within the microtubule lattice. The β-subunit mutation A393V is located at the dimer-
dimer interface within the protofilament. (C) The primary resistance mutation at G142 is located
within the tubulin motif (teal) of the α-tubulin GTP binding site. The GTP moiety is colored
blue and residues contributing to GTP binding outside of the GGGTGS tubulin motif are colored
red. The primary mutation G142S is located in the binding site and interacts with the α-
phosphate. The S171A mutation also locates to the binding site; S171 interacts with the ribose
portion of GTP (GIGANT et al. 2000; LOWE et al. 2001).
FIGURE 4. — In order to assess relative fitness of the F52Y and G142S lines as well as the
strains derived from these lines, equivalent numbers of parasites from a specific mutant line and
wild type RH strain parasites expressing GFP were inoculated into culture and the relative
percentage of the each population was quantified over time during serial passage using flow
cytometry. The relative parasite concentrations were quantified at the time of complete host cell
lysis when the lysate was passed into a new flask of host cells containing parasites. The red line
indicates the behavior of G142S parasites in competition and the orange line is the G142S
suppressor line β-P61A (located in the β-tubulin H1-S2 loop). The green line follows a
competition assay containing F52Y and the teal line represents behavior of the F52Y secondary
mutation α-P364R (located in the α-tubulin specific insert). The G142S parasites are out-
competed by GFP-RH parasites by day 6 whereas the β-P61A suppressor line persists until day
24. The F52Y parasites are eliminated at day 12 but in the presence of the α-P364R secondary
mutation, they are still present, albeit at reduced levels, when the competition was terminated at
27
30 days. The purple line traces the control competition between wild-type (untransfected RH
strain parasites) and the GFP-transfected “wild-type” RH strain line. Unlabeled parasites have a
growth advantage over GFP-transfected parasites. (Inset) A representative FACS dot plot of
DG52-labeled (red) parasites showing relative numbers of GFP-expressing wild type
Toxoplasma and a mutant line after a single passage.
FIGURE 5. — Replication fitness and oryzalin resistance in F52Y parasites and the derived
lines. Black bars: the percentage of mutant parasites relative to GFP-RH parasites after 7
passages (14 days). The assays were carried out in triplicate and error bars indicate standard
error of the mean. Gray bars: oryzalin resistance levels observed for F52Y parasites and the
derived lines.
FIGURE 6. — Replication fitness and oryzalin resistance in G142S parasites and the 24 derived
lines. Black bars: the percentage of mutant parasites relative to GFP-RH parasites after 7
passages (14 days). The assays were carried out in triplicate and error bars indicate standard
error of the mean. Gray bars: oryzalin resistance levels observed in G142S parasites and the
derived lines.